A Practical Review of Insulin Pen Devices

A Practical Review of Insulin Pen Devices

October 31, 2014 at 9:34 AM 0 comments

*Teresa L. Pearson Director, Clinical Services at Innovative Health Care Designs, LLC, Minneapolis, Minnesota, USA *Correspondence to tpearson9@comcast.net Disclosure: No potential conflict of interest. Received: 06.05.14 Accepted: 21.07.14 Citation: EMJ Diabet. 2014;2:58-64. Abstract Since the advent of insulin pens in 1985, there have been ongoing improvements providing several advantages overRead More

Membrane Flexibility and Cellular Energy Management in Type 2 Diabetes, Gestational Diabetes, and Obesity

Membrane Flexibility and Cellular Energy Management in Type 2 Diabetes, Gestational Diabetes, and Obesity

October 31, 2014 at 9:29 AM 0 comments

*Rob N.M. Weijers Teaching Hospital, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands *Correspondence to robw01@xs4all.nl Disclosure: No potential conflict of interest. Received: 10.04.14 Accepted: 01.08.14 Citation: EMJ Diabet. 2014;2:65-72. Abstract In the search to understand the onset of life’s biochemistry, scientists attached a great deal of importance to unravelling theRead More

Targeting Adipose Tissue Lipid Metabolism to Improve Glucose Metabolism in Cardiometabolic Disease

Targeting Adipose Tissue Lipid Metabolism to Improve Glucose Metabolism in Cardiometabolic Disease

October 31, 2014 at 9:22 AM 0 comments

*Johan W.E. Jocken, Gijs H. Goossens, Ellen E. Blaak Department of Human Biology, NUTRIM School for Nutrition, Toxicology, and Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands *Correspondence to j.jocken@maastrichtuniversity.nl Disclosure: No potential conflict of interest. Received: 27.05.14 Accepted: 20.08.14 Citation: EMJ Diabet. 2014;2:73-82. Abstract With Type 2 diabetes mellitusRead More

Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination

Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination

October 31, 2014 at 9:16 AM 0 comments

Angelos Liontos, Moses S. Elisaf, *Theodosios D. Filippatos Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece *Correspondence to filtheo@gmail.com Disclosure: No potential conflict of interest. Received: 02.05.14 Accepted: 31.07.14 Citation: EMJ Diabet. 2014;2:83-87. Abstract Patients with Type 2 diabetes mellitus (T2DM) have increased cardiovascular disease (CVD)Read More

Pathophysiology and Imaging Techniques of Diabetic Heart Disease

Pathophysiology and Imaging Techniques of Diabetic Heart Disease

October 31, 2014 at 9:13 AM 0 comments

Danielle L. Harrop,1 William Y.S. Wang,1,2 *Arnold C.T. Ng1,2 1. Department of Cardiology, Princess Alexandra Hospital, Brisbane, Australia 2. The University of Queensland, Brisbane, Australia *Correspondence to arnoldct@hotmail.com Disclosure: Ng is supported by the NHMRC early career fellowship. Wang and Ng both have joint senior authorship. Received: 28.04.14 Accepted: 05.08.14Read More

Exercise: A Powerful Tool to Manage Type 2 Diabetes in the Ageing Population

Exercise: A Powerful Tool to Manage Type 2 Diabetes in the Ageing Population

October 31, 2014 at 9:06 AM 0 comments

*Silvano Zanuso Technogym Medical Scientific Department, University of Greenwich, London, UK *Correspondence to szanuso@gmail.com Disclosure: No potential conflict of interest. Received: 28.04.14 Accepted: 21.07.14 Citation: EMJ Diabet. 2014;2:99-104. Abstract The aim of this paper is to highlight the evidence on the interrelationships between exercise and Type 2 diabetes mellitus (T2DM)Read More

Who Gets Diabetic Macular Oedema; When; and Why? Pathogenesis and Risk Factors

Who Gets Diabetic Macular Oedema; When; and Why? Pathogenesis and Risk Factors

October 31, 2014 at 9:03 AM 0 comments

*Banu Turgut Ozturk Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya, Turkey *Correspondence to ozturkbanuturgut@yahoo.com Disclosure: No potential conflict of interest. Received: 16.06.14 Accepted: 08.09.14 Citation: EMJ Diabet. 2014;2:105-111. Abstract Diabetic macular oedema (DMO) presents an enormous rise in the last decades with an increasing number of diabetic patients.Read More

Mortality in Patients with PAD with Respect to Glycaemic Status – A Review

Mortality in Patients with PAD with Respect to Glycaemic Status – A Review

November 11, 2013 at 11:57 PM 0 comments

Iren D. Hjellestad,1 Torbjørn Jonung2,3 1. Department of Medicine, Haukeland University Hospital, Bergen, Norway 2. Department of Vascular Surgery, Haukeland University Hospital, Bergen, Norway 3. Department of Clinical Sciences, University of Bergen, Bergen, Norway Disclosure: No potential conflict of interest. Acknowledgement: Authors would like to thank Eirik Søfteland, MD, PhDRead More

Is it Time to Transform Our Treatment Of Type 2 Diabetes

Is it Time to Transform Our Treatment Of Type 2 Diabetes

November 1, 2013 at 11:22 PM 0 comments

Summary of Presentations from the Bristol Myers Squibb/AstraZeneca Alliance Symposium, European Association for the Study of Diabetes (EASD) 49th Annual Congress, Barcelona, Spain, 23rd September 2013. Chairpersons: Michael Nauck,1 Dídac Mauricio,2 Anthony Barnett3 Speakers: Tina Vilsbøll,4 Samy Hadjadj,5 Peter Rossing,6 Edoardo Mannucci,7 Harald Darius,8 Chantal Mathieu9 1. Head, Diabeteszentrium Bad Lauterberg, Harz,Read More

Diabetes Mellitus and Periodontitis – Signs of a Bidirectional Relationship

Diabetes Mellitus and Periodontitis – Signs of a Bidirectional Relationship

October 30, 2013 at 11:25 PM 0 comments

Pınar Gümüş, Nurcan Buduneli Department of Periodontology, School of Dentistry, Ege University, İzmir, Turkey Disclosure: No potential conflict of interest. Received: 15.05.13 Accepted: 30.10.13 Citation: EMJ Diabet. 2013;1:30-36. Abstract Periodontitis is a multifactorial, irreversible and cumulative condition, initiated and propagated by bacteria and host factors. The multifactorial nature of periodontitisRead More